J&J Polishes SAPPHIRE Carotid Trial For HCFA Conditional Coverage Appraisal

Johnson & Johnson Cordis plans to submit an investigational device exemption application to FDA in March or April for the SAPPHIRE carotid stent trial, as discussions continue with the Health Care Financing Administration to secure reimbursement coverage.